StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TVGN

Tevogen Bio Holdings Inc.

TVGNW Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.05
+0.00 +3.71%

Key statistics

from XBRL data in SEC filings
Market cap
$199K
Revenue (TTM)
Net income (TTM)
-$21.4M
EPS (TTM)
$-6.44
P/E ratio
Dividend yield
Free cash flow
-$12.4M
Cash
$692K
Total assets
$4.92M
Gross margin
52-week range
$0.04 – $0.05

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Amended charter or bylaws Jul 30, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Delisting notice or listing-rule failure Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Other events Mar 25, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 4, 2026 8-K Director or officer change; Shareholder vote results Feb 25, 2026 8-K Regulation FD disclosure Jan 30, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Delisting notice or listing-rule failure Sep 26, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Jul 10, 2025 8-K Entered a material agreement Jul 3, 2025 8-K Other events Jun 30, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Entered a material agreement Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Amended charter or bylaws Apr 25, 2025 8-K Regulation FD disclosure Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Apr 2, 2025 8-K Regulation FD disclosure; Other events Jan 28, 2025 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K/A Entered a material agreement; Unregistered sale of equity Aug 26, 2024 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Amended charter or bylaws Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Terminated a material agreement; Delisting notice or listing-rule failure Jun 21, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 11, 2024 8-K/A May 30, 2024 10-Q Quarter ended 2024-03-31 May 28, 2024 8-K Entered a material agreement May 16, 2024 8-K Changed accountants May 2, 2024 8-K/A Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Apr 29, 2024 8-K Results of operations (earnings release) Apr 26, 2024 8-K/A Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Apr 10, 2024 8-K Entered a material agreement; Amended charter or bylaws Apr 2, 2024 8-K Amended charter or bylaws Mar 21, 2024 8-K Item 5.05 Feb 21, 2024 8-K/A Entered a material agreement; Unregistered sale of equity; Other events Feb 20, 2024